1 domain / 2 areas / 1 specialization
Clinilabs
Global CNS-focused full-service CRO operating Phase 1 research units and end-to-end trial services, with documented psychedelic and hallucinogenic clinical studies and controlled-substance trial infrastructure.
Clinical Trial Infrastructure Snapshot
CROs & Full-Service Trial DeliveryService Model
Full-Service CRO
Coverage
Global
Psychedelic Experience
Verified Psychedelic Trial Experience
Last Verified
Apr 8, 2026
Lifecycle Coverage
Phase Coverage
Capabilities
Verification
Verified
Experience Notes
Clinilabs publicly lists active psychedelic and hallucinogenic volunteer studies and announced Schedule I license support for the CYB003 first-in-human psilocybin-analog trial.
Service Notes
CNS-specialist CRO with global Phase 1-3 capabilities, dedicated units approved for Schedule 1-5 substances, and combined operational, medical monitoring, and data services.
Source Evidence
Clinilabs — About
https://clinilabs.com/About/
Clinilabs — Healthy Volunteer Psychedelic Study
https://clinilabs.com/volunteer-study/healthy-volunteer-psychedelic-study/
Clinilabs — CYB003 Schedule I License Announcement
https://clinilabs.com/cyb003prsched1/
Clinilabs — New Jersey Phase 1 Unit
https://clinilabs.com/new-jersey-unit/
Quick Facts
- Website
- Visit